235 related articles for article (PubMed ID: 10814523)
61. Farnesyl acetate, a derivative of an isoprenoid of the mevalonate pathway, inhibits DNA replication in hamster and human cells.
Meigs TE; Sherwood SW; Simoni RD
Exp Cell Res; 1995 Aug; 219(2):461-70. PubMed ID: 7641798
[TBL] [Abstract][Full Text] [Related]
62. Molecular cloning and analysis of the 5'-flanking region of the human bone morphogenetic protein-6 (BMP-6).
Tamada H; Kitazawa R; Gohji K; Kamidono S; Maeda S; Kitazawa S
Biochim Biophys Acta; 1998 Feb; 1395(3):247-51. PubMed ID: 9512655
[TBL] [Abstract][Full Text] [Related]
63. Simvastatin enhances bone morphogenetic protein receptor type II expression.
Hu H; Sung A; Zhao G; Shi L; Qiu D; Nishimura T; Kao PN
Biochem Biophys Res Commun; 2006 Jan; 339(1):59-64. PubMed ID: 16297860
[TBL] [Abstract][Full Text] [Related]
64. Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation.
Kitazawa S; Kitazawa R; Obayashi C; Yamamoto T
J Bone Miner Res; 2005 Aug; 20(8):1472-7. PubMed ID: 16007344
[TBL] [Abstract][Full Text] [Related]
65. Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells.
Veerkamp JH; Smit JW; Benders AA; Oosterhof A
Biochim Biophys Acta; 1996 Apr; 1315(3):217-22. PubMed ID: 8611662
[TBL] [Abstract][Full Text] [Related]
66. Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2).
Paralkar VM; Grasser WA; Mansolf AL; Baumann AP; Owen TA; Smock SL; Martinovic S; Borovecki F; Vukicevic S; Ke HZ; Thompson DD
J Cell Physiol; 2002 Feb; 190(2):207-17. PubMed ID: 11807825
[TBL] [Abstract][Full Text] [Related]
67. [A quantitative immunohistochemical analysis of bone morphogenetic protein (BMP) in osteosarcoma of jaw].
Jin Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Sep; 26(5):276-8, 316-7. PubMed ID: 1815858
[TBL] [Abstract][Full Text] [Related]
68. BMP regulation of the mouse connexin43 promoter in osteoblastic cells and embryos.
Chatterjee B; Meyer RA; Loredo GA; Coleman CM; Tuan R; Lo CW
Cell Commun Adhes; 2003; 10(1):37-50. PubMed ID: 12881039
[TBL] [Abstract][Full Text] [Related]
69. Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cells.
Ekström L; Johansson M; Monostory K; Rundlöf AK; Arnér ES; Björkhem-Bergman L
Biochem Biophys Res Commun; 2013 Jan; 430(1):90-4. PubMed ID: 23154180
[TBL] [Abstract][Full Text] [Related]
70. Osteogenic protein-1 stimulates mRNA levels of BMP-6 and decreases mRNA levels of BMP-2 and -4 in human osteosarcoma cells.
Honda Y; Knutsen R; Strong DD; Sampath TK; Baylink DJ; Mohan S
Calcif Tissue Int; 1997 Mar; 60(3):297-301. PubMed ID: 9069169
[TBL] [Abstract][Full Text] [Related]
71. Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth.
Emmanuele L; Ortmann J; Doerflinger T; Traupe T; Barton M
Biochem Biophys Res Commun; 2003 Feb; 302(1):67-72. PubMed ID: 12593849
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of mevalonate synthesis with compactin does not prevent DNA replication in cultured animal cells.
Braithwaite AW; Palni LM
Eur J Cell Biol; 1986 Jun; 41(1):121-6. PubMed ID: 3792333
[TBL] [Abstract][Full Text] [Related]
73. Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions.
Yang LJ; Jin Y
Clin Orthop Relat Res; 1990 Aug; (257):249-56. PubMed ID: 2379362
[TBL] [Abstract][Full Text] [Related]
74. Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells.
Raval P; Hsu HH; Schneider DJ; Sarras MP; Masuhara K; Bonewald LF; Anderson HC
J Dent Res; 1996 Jul; 75(7):1518-23. PubMed ID: 8876605
[TBL] [Abstract][Full Text] [Related]
75. Solubilized bone morphogenetic protein (BMP) from mouse osteosarcoma and rat demineralized bone matrix.
Hanamura H; Higuchi Y; Nakagawa M; Iwata H; Nogami H; Urist MR
Clin Orthop Relat Res; 1980 May; (148):281-90. PubMed ID: 6929747
[TBL] [Abstract][Full Text] [Related]
76. [Stimulation of bone formation by statins].
Komatsu Y; Nakao K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():783-8. PubMed ID: 15035227
[No Abstract] [Full Text] [Related]
77. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.
Garrett IR; Chen D; Gutierrez G; Zhao M; Escobedo A; Rossini G; Harris SE; Gallwitz W; Kim KB; Hu S; Crews CM; Mundy GR
J Clin Invest; 2003 Jun; 111(11):1771-82. PubMed ID: 12782679
[TBL] [Abstract][Full Text] [Related]
78. Purification and characterization of a bone-inducing protein from a murine osteosarcoma (Dunn type).
Takaoka K; Yoshikawa H; Hashimoto J; Miyamoto S; Masuhara K; Nakahara H; Matsui M; Ono K
Clin Orthop Relat Res; 1993 Jul; (292):329-36. PubMed ID: 8519128
[TBL] [Abstract][Full Text] [Related]
79. Treatment of mammalian cells with the endoplasmic reticulum-proliferator compactin strongly induces recombinant and endogenous xenobiotic metabolizing enzymes and 3-hydroxy-3-methylglutaryl-CoA reductase in vitro.
McLaughlin L; Burchell B; Pritchard M; Wolf CR; Friedberg T
J Cell Sci; 1999 Feb; 112 ( Pt 4)():515-23. PubMed ID: 9914163
[TBL] [Abstract][Full Text] [Related]
80. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
Goto D; Okimoto T; Ono M; Shimotsu H; Abe K; Tsujita Y; Kuwano M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
